Scarica l'app Stockscreener
377.96
0.28%
1.56
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ELV Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$376.40
Aprire:
$376.01
Volume 24 ore:
262.63K
Relative Volume:
0.15
Capitalizzazione di mercato:
$81.90B
Reddito:
$201.11B
Utile/perdita netta:
$4.95B
Rapporto P/E:
16.80
EPS:
22.4991
Flusso di cassa netto:
$6.29B
1 W Prestazione:
-0.06%
1M Prestazione:
-2.39%
6M Prestazione:
+9.18%
1 anno Prestazione:
+33.34%
Intervallo 1D:
$373.16
$380.04
Intervallo di 1 settimana:
$362.98
$388.73
Portata 52W:
$273.71
$436.24
Elevance Health Inc Stock (ELV) Company Profile
Nome
Elevance Health Inc
Settore
Industria
Telefono
(800) 331-1476
Indirizzo
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
377.65 | 82.05B | 201.11B | 4.95B | 6.29B | 22.50 |
UNH
Unitedhealth Group Inc
|
419.71 | 379.28B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
105.36 | 136.61B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
282.88 | 76.98B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
367.20 | 45.76B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-08 | Iniziato | Evercore ISI | In-line |
| 2026-02-03 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Iniziato | Goldman | Neutral |
| 2025-07-21 | Downgrade | Argus | Buy → Hold |
| 2025-07-18 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Aggiornamento | Argus | Hold → Buy |
| 2025-01-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Downgrade | Argus | Buy → Hold |
| 2024-07-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-06-24 | Iniziato | Morgan Stanley | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-07-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
Mostra tutto
Elevance Health Inc Borsa (ELV) Ultime notizie
AE1N Bond Profile — Key Metrics - TradingView
Elevance Health, Inc. (ELV) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (ELV) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (ELV) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
President of Elevance Health Gail Boudreaux Buys 1.9% More Shares - simplywall.st
Elevance Health, Inc. (ELV) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (ELV) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (ELV) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health stock holds on earnings and guidance - AD HOC NEWS
Elevance Health Inc (ELV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Elevance Health Market Sentiment - Benzinga España
Elevance Health, Inc. (A58) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health stock trades steadily as recent earnings highlight Medicaid growth and margin resili - AD HOC NEWS
ELV|Elevance Health Inc|Price:377.680|Chg%:-1.870 - TradingKey
AE1H Bond Profile — Key Metrics - TradingView
Elevance Health, Inc. (A58) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (A58) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
AE1P Bond Profile — Key Metrics - TradingView
Vanguard Windsor II Fund's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health (ELV) Stock Still Looks Reasonable After A 43% Run - Yahoo Finance
Elevance Health stock trades steadily as earnings and Medicare growth shape investor focus - Ad-hoc-news.de
Elevance Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
The Hidden Engine Behind Elevance Health Stock's Next Climb - Trefis
Elevance Health stock trades steadily as earnings and Medicaid growth shape investor focus - Ad-hoc-news.de
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health Inc Stock Price Live, Charts & News - The Economic Times
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now? - The Motley Fool
AE1D Bond Profile — Key Metrics - TradingView
AE1J Bond Profile — Key Metrics - TradingView
Elevance Health President Acquires 1.9% More Stock - Moomoo
Elevance Health director Peru buys $366,050 in company stock - Investing.com UK
Elevance Preparing to Exit Several Medicaid States - RamaOnHealthcare
Elevance Health CEO Gail Boudreaux acquires common shares worth $1,003,428.45 - Bitget
Elevance Health Price Target Raised to $395.00/Share From $364.00 by Leerink Partners - Moomoo
Insider Buying: Ramiro Peru Acquires Shares of Elevance Health I - GuruFocus
Elevance Health CEO Snaps Up Stock After Post-Earnings Slide - Barron's
Elevance Health director Peru buys $366,050 in company stock By Investing.com - Investing.com South Africa
Elevance Health, Inc. $ELV Shares Acquired by Bank of New York Mellon Corp - InsuranceNewsNet
What's a Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets? - Trefis
Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook? - The Motley Fool
Elevance Health (NYSE: ELV) director purchases 1,000 shares at $366 - Stock Titan
Form 4 Elevance Health Inc For: 17 July By Investing.com - Investing.com South Africa
Elevance Health (NYSE: ELV) CEO Gail Boudreaux purchases 2,725 shares - Stock Titan
Elevance Health CEO Gail Boudreaux buys $1.0m in company stock By Investing.com - Investing.com Australia
Elevance Health CEO Gail Boudreaux buys $1.0m in company stock - Investing.com Nigeria
Leerink Partners Adjusts PT on Elevance Health to $395 From $364, Maintains Market Perform Rating - Moomoo
Bernstein Adjusts Price Target on Elevance Health to $488 From $482, Maintains Outperform Rating - Moomoo
Leerink Partners Maintains Elevance Health(ELV.US) With Hold Rating, Raises Target Price to $395 - Moomoo
Elevance Health's Strong Q2 Prompts Higher 2026-27 Estimates, Truist Says - Moomoo
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Pfizer (PFE) - The Globe and Mail
These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings - Sahm
Elevance Health Inc Azioni (ELV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Elevance Health Inc Azioni (ELV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BOUDREAUX GAIL | President and CEO |
Jul 17 '26 |
Buy |
367.79 |
2,725 |
1,002,230 |
171,976 |
1.69%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):